These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17460971)

  • 1. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
    Belousov IuB; Karpov OI; Belousov DIu; Beketov AS
    Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
    Shuter J; Fletcher DD; Simone VJ; Bellin EY
    J Urban Health; 1998 Dec; 75(4):896-902. PubMed ID: 9854250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases].
    Samsonov AA; Grechushnikov VB; Andreev DN; Iurenev GL; Korovina TI; Lezhneva IuA; Maev IV
    Ter Arkh; 2014; 86(8):56-61. PubMed ID: 25306745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
    Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
    Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of H. pylori infection: the reality.
    Vakil N
    Yale J Biol Med; 1998; 71(2):119-24. PubMed ID: 10378357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
    Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
    Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
    Gisbert JP; Boixeda D; Martín de Argila C
    Rev Esp Enferm Dig; 1997 Feb; 89(2):116-23. PubMed ID: 9115818
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication.
    Treiber G; Walker S; Klotz U
    Arzneimittelforschung; 1997 Jan; 47(1):47-50. PubMed ID: 9037444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 19. Quadruple therapy: the golden bullet or a drug too far?
    Moayyedi P
    Helicobacter; 1996 Jun; 1(2):123-4. PubMed ID: 9398891
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.